E. Canalis (Barcelona, Spain)
Toxicity in isolated lung perfusion with melphalan for resectable lung metastases M. J. J. H. Grootenboers, J. M. Hendriks, W. J. van Boven, C. A. J. Knibbe, P. E. Van Schil, F. M. Schramel (Nieuwegein, Netherlands; Edegem, Belgium)
| |
Can we still justify pneumonectomy following induction chemotherapy? Z. Mansour, X. Ducrocq, M. Vasilesu, J. M. Wihlm, E. Quoix, G. Massard (Strasbourg, France)
| |
Surgical resection of carcinoid lung tumours. A population based study A. Naalsund, H. Rostad, T. E. Strand (Oslo, Norway)
| |
A low endothelial cell proliferation fraction, a measurement of ongoing angiogenesis, is associated with poor prognosis in non-small cell lung cancer P. Sardari Nia, C. Colpaert, P. Vermeulen, E. Van Marck, P. Van Schil (Antwerp, Belgium)
| |
Centralisation of thoracic surgery services to a regional centre – the impact on cancer waiting times K. Lilley, D. Saralaya, B. Jacob, D. Newton, A. Harwood (Bradford, United Kingdom)
| |
Prognostic value of comorbidity in operated non-small cell lung cancer P. Sardari Nia, E. Van Marck, P. Van Schil (Antwerp, Belgium)
| |
Clinical characteristics of postoperative pulmonary infection in lung cancer patients with obstructive pulmonary disease: the trend of microorganisms in bronchial colonization Y. Yamada, Y. Sekine, H. Suzuki, T. Nakajima, T. Iwata, M. Chiyo, K. Yasufuku, A. Iyoda, M. Suzuki, K. Shibuya, T. Iizasa, T. Fujisawa (Chiba, Japan)
| |
Coronary artery disease and lung cancer surgery M. Peka, U. Kopeika, A. Erglis, I. Kumsars, I. Zakke, J. Basko (Riga, Latvia)
| |